Compare SRPT & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | PBI |
|---|---|---|
| Founded | 1980 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2000 | 1994 |
| Metric | SRPT | PBI |
|---|---|---|
| Price | $18.68 | $16.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 29 | 3 |
| Target Price | ★ $25.85 | $13.00 |
| AVG Volume (30 Days) | ★ 3.0M | 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ 175.00 |
| EPS | ★ 2.99 | 0.75 |
| Revenue | ★ $2,198,237,000.00 | $1,892,629,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $6.15 | $21.81 |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $14.68 | $8.95 |
| 52 Week High | $25.32 | $19.07 |
| Indicator | SRPT | PBI |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 40.79 |
| Support Level | $15.40 | $15.09 |
| Resistance Level | $23.80 | $16.56 |
| Average True Range (ATR) | 1.30 | 0.41 |
| MACD | -0.41 | -0.09 |
| Stochastic Oscillator | 13.06 | 23.99 |
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.